FI120199B - Substituoituja N-etyyliglysiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö PNA- ja PNA-/DNA-hybridien valmistamiseksi - Google Patents

Substituoituja N-etyyliglysiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö PNA- ja PNA-/DNA-hybridien valmistamiseksi Download PDF

Info

Publication number
FI120199B
FI120199B FI951128A FI951128A FI120199B FI 120199 B FI120199 B FI 120199B FI 951128 A FI951128 A FI 951128A FI 951128 A FI951128 A FI 951128A FI 120199 B FI120199 B FI 120199B
Authority
FI
Finland
Prior art keywords
compound
formula
mixture
evaporated
protecting group
Prior art date
Application number
FI951128A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951128A0 (fi
FI951128A (fi
Inventor
Eugen Uhlmann
Gerhard Breipohl
Jochen Knolle
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI951128A0 publication Critical patent/FI951128A0/fi
Publication of FI951128A publication Critical patent/FI951128A/fi
Application granted granted Critical
Publication of FI120199B publication Critical patent/FI120199B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI951128A 1994-03-14 1995-03-10 Substituoituja N-etyyliglysiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö PNA- ja PNA-/DNA-hybridien valmistamiseksi FI120199B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4408534 1994-03-14
DE4408534A DE4408534A1 (de) 1994-03-14 1994-03-14 Substituierte N-Ethyl-Glycinderivate zur Herstellung von PNA und PNA-/DNA-Hybriden

Publications (3)

Publication Number Publication Date
FI951128A0 FI951128A0 (fi) 1995-03-10
FI951128A FI951128A (fi) 1995-09-15
FI120199B true FI120199B (fi) 2009-07-31

Family

ID=6512698

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951128A FI120199B (fi) 1994-03-14 1995-03-10 Substituoituja N-etyyliglysiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö PNA- ja PNA-/DNA-hybridien valmistamiseksi

Country Status (8)

Country Link
US (1) US6075143A (ja)
EP (1) EP0672661A1 (ja)
JP (1) JPH07258222A (ja)
AU (1) AU686729B2 (ja)
CA (1) CA2144474C (ja)
DE (1) DE4408534A1 (ja)
FI (1) FI120199B (ja)
NO (1) NO307705B1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133444A (en) 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
US6919441B2 (en) * 1994-03-14 2005-07-19 Aventis Pharma Deutschland Gmbh Polyamide-oligonucleotide derivatives, their preparation and use
DE69632324T2 (de) 1995-06-07 2005-06-16 PerSeptive Biosystems, Inc., Framingham Pna-dna-chimäre und pna-synthone zu deren herstellung
DE19532553A1 (de) * 1995-09-04 1997-03-06 Hoechst Ag Verfahren zur Herstellung substituierter N-Ethyl-Glycinderivate
US6191165B1 (en) 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
DE19640974A1 (de) * 1996-10-04 1998-04-16 Bayer Ag Bausteine für DNA/PNA-Cooligomere
EP0983290B1 (de) * 1997-05-14 2004-03-03 Morphochem AG Verfahren zur herstellung von polymeren, die nucleobasen als seitengruppen aufweisen
US9879012B2 (en) 2012-03-29 2018-01-30 Regents Of The University Of Colorado, A Body Corporate Click nucleic acids
CA2938875A1 (en) 2014-02-06 2015-08-13 The Regents Of The University Of Colorado, A Body Corporate Thiol-x click foldamers for polymer affinity and catalysis libraries
CN105541728B (zh) * 2015-07-27 2018-07-24 宁夏联森生物科技有限公司 一种n-4苯甲酰基胞嘧啶的制备方法
US10508116B2 (en) 2016-10-07 2019-12-17 The Regents Of The University Of Colorado, A Body Click nucleic acid polymers and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2627988A1 (de) * 1976-06-23 1978-01-05 Max Planck Gesellschaft Sekretinbestimmung
US4213968A (en) * 1978-06-05 1980-07-22 Coy David Howard Enkephalin derivatives
US4213893A (en) * 1978-10-12 1980-07-22 Miles Laboratories, Inc. Flavin adenine dinucleotide-labeled conjugates for use in specific binding assays
JPS55135595A (en) * 1979-04-03 1980-10-22 Toyo Soda Mfg Co Ltd Preparation of dipeptide
US5470974A (en) * 1985-03-15 1995-11-28 Neu-Gene Development Group Uncharged polynucleotide-binding polymers
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
US5227497A (en) * 1988-04-04 1993-07-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing N2 -(1-carboxy-3-phenylpropyl)-L-lysine derivative
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
DE4016596A1 (de) * 1990-05-23 1991-11-28 Hoechst Ag Ein neues kupplungsreagenz fuer die peptidsynthese
US5614498A (en) * 1990-06-07 1997-03-25 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic substance
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
US5539082A (en) * 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
MX9207334A (es) * 1991-12-18 1993-08-01 Glaxo Inc Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene
EP0605729B1 (en) * 1992-04-30 2000-07-26 Taiho Pharmaceutical Co., Ltd. Oxazolidine derivative and pharmaceutically acceptable salt thereof
DE4331012A1 (de) * 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
DE69430704T2 (de) * 1993-12-22 2003-01-30 Perseptive Biosystems, Inc. Guaninsynthone für die synthese von nucleinsäuren und verfahren zu deren herstellung
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities

Also Published As

Publication number Publication date
NO307705B1 (no) 2000-05-15
FI951128A0 (fi) 1995-03-10
AU686729B2 (en) 1998-02-12
EP0672661A1 (de) 1995-09-20
FI951128A (fi) 1995-09-15
JPH07258222A (ja) 1995-10-09
NO950959D0 (no) 1995-03-13
DE4408534A1 (de) 1995-09-28
CA2144474C (en) 2010-11-30
US6075143A (en) 2000-06-13
AU1479995A (en) 1995-09-21
CA2144474A1 (en) 1995-09-15
NO950959L (no) 1995-09-15

Similar Documents

Publication Publication Date Title
CA2144477C (en) Pna synthesis using an amino protecting group which is labile to weak acids
AU708034B2 (en) Process for preparing substituted N-ethylglycine derivatives
FI120199B (fi) Substituoituja N-etyyliglysiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö PNA- ja PNA-/DNA-hybridien valmistamiseksi
US6713603B2 (en) Chiral peptide nucleic acids
US5977302A (en) Liquid phase process for the preparation of GnRH peptides
CA2942143A1 (en) Pharmaceutically relevant aromatic-cationic peptides and methods of generating the same
US11976094B2 (en) Method for preparing peptides
CA2144473C (en) Pna synthesis using a base-labile amino protecting group
Kuwahara et al. Synthesis of δ-amino acids with an ether linkage in the main chain and nucleobases on the side chain as monomer units for oxy-peptide nucleic acids
US6465650B1 (en) Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids
US20040101864A1 (en) Chemical process
Komori et al. Structure activity relationships of synthetic antibiotic analogues of chryscandin
KR100543980B1 (ko) 2-(4-니트로페닐)설포닐에톡시카르보닐 치환된 아미노산유도체와 이의 제조방법

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120199

Country of ref document: FI

MM Patent lapsed